BD received 510(k) clearance for COVID-19, influenza A/B, RSV molecular combination test
On Aug. 1, 2023, BD announced that the U.S. Food and Drug Administration (FDA) 510(k) had provided clearance…
On Aug. 1, 2023, BD announced that the U.S. Food and Drug Administration (FDA) 510(k) had provided clearance…
On Jul. 31, 2023, Emergent BioSolutions announced that it was awarded a 10-year contract by the Biomedical Advanced…
On Jul. 28, 2023, COVID vaccine uptake among hospital workers at a Philadelphia teaching hospital rose from 86%…
On Jul. 28, 2023, the World Health Organization (WHO) reported circulating vaccine-derived poliovirus type 2 (cVDPV2) in the…
On Jul. 28, 2023, the U.S. Food and Drug Administration (FDA) approved Merck’s Ervebo, a vaccine for the…
On Jul. 24, 2023, the Journal JAMA reported there is evidence that Republican-leaning counties had higher COVID-19 death…
On Jul. 14, 2023, the UK Animal and Plant Health Agency reported that additional asymptomatic human detections of…
On Jul. 5, 2023, the IHR National Focal Point of Poland notified WHO of unusual deaths in cats…
On Jun. 26, 2023, the Centers for Disease Control and Prevention (CDC) announced they were collaborating with U.S….
On Jun. 16, 2023, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee…
On May 31, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
On May 30, 2023, the United Kingdom of Great Britain and Northern Ireland reported to the World Health…
On May 26, 2023, Novavax announced that Nuvaxovid (NVX-CoV2373) had been recommended for full Marketing Authorization (MA) for…
On May 3, 2023, the U.S. FDA approved GlaxoSmithKline’s Arexvy as the first respiratory syncytial virus (RSV) vaccine…
On Apr. 27, 2023, a NIAID-led Phase 2 trial compared two Pfizer bivalent mRNA COVID-19 boosters found that…
On Apr. 27, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
On Apr. 23, 2023, the most comprehensive state-by-state analysis of the impacts of COVID-19 across the USA, published…
On Apr. 10, 2023, the U.S. Department of Health and Human Services (HHS) announced it was spending over…
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
On Apr. 5, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
On Apr. 4, 2023, National Institutes of Health (NIH) funded research was announced from the University of Rochester…
On Mar. 30, 2023, Moderna and the Government of the Republic of Kenya announced they had finalized an…
On Mar. 29, 2023, the World Health Organization (WHO) announced that it had certified Azerbaijan and Tajikistan for…
On Mar. 29, 2023, the mortality gap between the United States and other high-income nations substantially expanded during…
On Mar. 27, 2023, the National Health Commission of the People’s Republic of China reported a confirmed case…
On Mar. 24, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Tuberculosis (TB) in…
On Mar. 21, 2023, the Ministry of Health of the United Republic of Tanzania declared an outbreak of…
On Mar. 20, 2023, National Institutes of Health (NIH) scientists announced that the magnitude and quality of a…
On Mar. 20, 2023, some of the world’s leading makers of flu vaccines said they could make hundreds…
On Mar. 17, 2023, the Indonesia Ministry of Health notified the World Health Organization (WHO) of the detection…